Trieu Vuong bought OTLC
October 28, 2026 · Form 4 insider transaction
Trieu Vuong bought 312,000 shares of Oncotelic Therapeutics, Inc. at $0.02 per share, a transaction worth $5.8K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
312,000
Price
$0.02
Total value
$5.8K
InsiderTrieu Vuong
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateOctober 28, 2026
Filing dateOctober 30, 2026
Shares owned after94,436,319
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On October 28, 2026, Dr. Vuong Trieu purchased 312,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.0185.